How could alleged kickbacks threaten to render insolvent a publicly traded company with assets (taken from its latest SEC filing) in excess of $43 billion? The answer stems from a recent decision by the United States District...more
8/10/2023
/ Anti-Kickback Statute ,
Co-payments ,
False Claims Act (FCA) ,
False Statements ,
Health Insurance ,
Healthcare ,
Kickbacks ,
Medicare ,
Patient Assistance Programs ,
Pharmaceutical Industry ,
Publicly-Traded Companies ,
Securities and Exchange Commission (SEC) ,
Teva Pharmaceuticals